Novartis signs agreement to acquire Anthos for $925m upfront
Pharmaceutical Technology
FEBRUARY 11, 2025
Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.
Pharmaceutical Technology
FEBRUARY 11, 2025
Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.
Bio Pharma Dive
FEBRUARY 10, 2025
The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 6, 2025
The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or be used in new, multi-drug combinations.
Pharmaceutical Technology
FEBRUARY 7, 2025
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 6, 2025
(Jack Atkinson/Unsplash) We know that spending lots of time sitting down isn’t good for us, but just how much exercise is needed to counteract the negative health effects of sitting down all day? Research suggests about 30-40 minutes per day of building up a sweat should do it.
Medical Xpress
FEBRUARY 7, 2025
Virginia Tech neuroscientists have uncovered a mitochondrial process that supports the brain cells critical for learning, memory, and social recognition.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2025
(koto_feja/E+/Getty Images) A new model of Alzheimer’s disease has been proposed, which could speed up efforts to understand and cure the complex condition while bringing all manifestations of the condition under one unifying theory.
Medical Xpress
FEBRUARY 8, 2025
Mitochondria are essential for generating energy that fuels cells and helps them function.
Pharma Times
FEBRUARY 10, 2025
New methodology may boost innovation in protein engineering
Bio Pharma Dive
FEBRUARY 6, 2025
Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and is around 1,000 prescriptions weekly by late January.
Pharmaceutical Technology
FEBRUARY 11, 2025
Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease space.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 10, 2025
(Filipp Romanovski/Unsplash) If you look up at the sky on a clear day, you might notice little cobweb-like structures drifting across your field of vision.
Medical Xpress
FEBRUARY 8, 2025
Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of medications called JAK inhibitors, using an acronym that assumes the average TV watcher knows exactly what JAK stands for.
Pharma Times
FEBRUARY 10, 2025
CSL Behring's study reveals significant long-term benefits
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Bio Pharma Dive
FEBRUARY 10, 2025
Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.
Pharmaceutical Technology
FEBRUARY 7, 2025
Sanofi has agreed to purchase its own shares worth 2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2025
Indian pharmaceutical industry plays a crucial role in the global drug supply chain, particularly in the US. Yet India needs to develop strategies to mitigate the impact of USAID funding freeze for Indian pharma companies.
Medical Xpress
FEBRUARY 7, 2025
The U.S. winter virus season is in full force, and by one measure is the most intense in 15 years.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Rethinking Clinical Trials
FEBRUARY 6, 2025
Speakers Richard L. Skolasky, ScD Professor, Johns Hopkins School of Medicine Department of Orthopaedic Surgery Kevin H. McLaughlin, DPT Assistant Professor, Johns Hopkins School of Medicine Department of Physical Medicine and Rehabilitation Slides Keywords Back Pain; Rural Health; Telehealth Key Points Low back pain (LBP) is the most common cause of disability globally and in the U.S.
Bio Pharma Dive
FEBRUARY 6, 2025
The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies across multiple areas of the business,” its CFO told analysts on a conference call.
Pharmaceutical Technology
FEBRUARY 10, 2025
Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 12, 2025
(Dusty Pixel photography/Getty Images) An emerging strain of highly pathogenic avian influenza has spilled over from wild birds to dairy cows in the state of Nevada, and officials at the US Department of Agriculture (USDA) and some scientists are concerned by a mutation they are seeing. The viral variant, called genotype D1.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Medical Xpress
FEBRUARY 8, 2025
Years ago, a young patient's mother told Emily McCourt, MD, associate professor of ophthalmology at the University of Colorado School of Medicine, that she hadn't used a prescribed ointment to treat her baby's chemical corneal burn but instead used her own breast milk.
Pharma Times
FEBRUARY 12, 2025
UCB's BIMZELX reveals promising two-year data at EHSF 2025
Bio Pharma Dive
FEBRUARY 11, 2025
The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed to the Blackstone-backed startup six years ago.
Pharmaceutical Technology
FEBRUARY 10, 2025
Controversy surrounded Him & Hers commercial, called Sick of the System, in the lead up to Americas biggest sporting event.
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 12, 2025
The proposed budget allocation for the Central sector schemes of Department of Health Research (DHR), under the ministry of health and family welfare, is expected see an increase of almost 40 per cent during the fiscal year 2025-26, as compared to the initial projects under the Budget Estimates (BE) for the fiscal year 2024-25.
Medical Xpress
FEBRUARY 8, 2025
New research details the subcellular structures in neurons that enable signals to be transmitted from where they are received at specific sites on dendrites to the decision-making cell body located hundreds of micrometers away. The new research finds that the endoplasmic reticulum and the plasma membrane form contact sites where specialized molecules control the release of calcium, which regulates the signals sent along the dendrite to the soma.
pharmaphorum
FEBRUARY 10, 2025
AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.
Bio Pharma Dive
FEBRUARY 12, 2025
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed to establish a conclusive benefit.
Let's personalize your content